Register entry
- Registered sites
- 0
- Active NDC listings
- 32
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
3232 active NDC listings: 32 human prescription drug. By marketing category: ANDA 27, NDA 4, NDA AUTHORIZED GENERIC 1.
| Dosage form | NDCs |
|---|---|
| tablet | 10 |
| capsule | 7 |
| capsule, extended release | 3 |
| injection, solution | 3 |
| patch, extended release | 3 |
| tablet, film coated | 2 |
| capsule, delayed release pellets | 1 |
| cream | 1 |
| powder | 1 |
| syrup | 1 |
| Route | NDCs |
|---|---|
| oral | 24 |
| intravenous | 3 |
| transdermal | 3 |
| topical | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| dr. reddy's labratories inc. | 32 |
Catalogue
Marketed products
32| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Amiodarone Hydrochloride | Amiodarone Hydrochloride | tablet, oral | 75907-005ANDA |
| Amiodarone Hydrochloride | Amiodarone Hydrochloride | tablet, oral | 75907-006ANDA |
| Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide | Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide | syrup, oral | 75907-207ANDA |
| CAMILA | NORETHINDRONE | tablet, oral | 75907-074ANDA |
| CYCLOPHOSPHAMIDE | cyclophosphamide | injection, solution, intravenous | 75907-189NDA |
| CYCLOPHOSPHAMIDE | cyclophosphamide | injection, solution, intravenous | 75907-190NDA |
| CYCLOPHOSPHAMIDE | cyclophosphamide | injection, solution, intravenous | 75907-191NDA |
| Clonidine | CLONIDINE | patch, extended release, transdermal | 75907-023ANDA |
| Clonidine | CLONIDINE | patch, extended release, transdermal | 75907-024ANDA |
| Clonidine | CLONIDINE | patch, extended release, transdermal | 75907-025ANDA |
| DISOPYRAMIDE PHOSPHATE | DISOPYRAMIDE PHOSPHATE | capsule, oral | 75907-026ANDA |
| DISOPYRAMIDE PHOSPHATE | DISOPYRAMIDE PHOSPHATE | capsule, oral | 75907-027ANDA |
| Diltiazem Hydrochloride Extended-Release | Diltiazem Hydrochloride | capsule, extended release, oral | 75907-044ANDA |
| Diltiazem Hydrochloride Extended-Release | Diltiazem Hydrochloride | capsule, extended release, oral | 75907-045ANDA |
| Diltiazem Hydrochloride Extended-Release | Diltiazem Hydrochloride | capsule, extended release, oral | 75907-046ANDA |
| Dofetilide | Dofetilide | capsule, oral | 75907-054ANDA |
| Dofetilide | Dofetilide | capsule, oral | 75907-055ANDA |
| Dofetilide | Dofetilide | capsule, oral | 75907-056ANDA |
| ERRIN | NORETHINDRONE | tablet, oral | 75907-075ANDA |
| Estazolam | Estazolam | tablet, oral | 75907-028ANDA |
| Estazolam | Estazolam | tablet, oral | 75907-029ANDA |
| FLUOROURACIL | FLUOROURACIL | cream, topical | 75907-095ANDA |
| Liothyronine Sodium | Liothyronine Sodium | tablet, oral | 75907-001ANDA |
| Liothyronine Sodium | Liothyronine Sodium | tablet, oral | 75907-004ANDA |
| Liothyronine Sodium | Liothyronine Sodium | tablet, oral | 75907-039ANDA |
| Nystatin | Nystatin | powder, topical | 75907-060ANDA |
| Tamoxifen Citrate | Tamoxifen Citrate | tablet, film coated, oral | 75907-058ANDA |
| Tamoxifen Citrate | Tamoxifen Citrate | tablet, film coated, oral | 75907-059ANDA |
| Trimethoprim | Trimethoprim | tablet, oral | 75907-043NDA |
| butalbital and acetaminophen | butalbital and acetaminophen | capsule, oral | 75907-008ANDA |
| butalbital, acetaminophen and caffeine | butalbital, acetaminophen and caffeine | capsule, oral | 75907-009ANDA |
| erythromycin | erythromycin | capsule, delayed release pellets, oral | 75907-076NDA AUTHORIZED GENERIC |
Compare
Other companies listing clonidine
- Mayne Pharma International Pty Ltd.1 site · 64 NDC
Enquiry
Common questions
- Is Dr. Reddy's Labratories Inc. FDA approved?
- Dr. Reddy's Labratories Inc. holds no registered establishment of its own; 32 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Dr. Reddy's Labratories Inc. make?
- 32 products are listed under Dr. Reddy's Labratories Inc. in the openFDA NDC Directory, most often as tablet; capsule; capsule, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.